Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Behiye Kodal"'
Autor:
Felix Oh, Peter Hinderlie, Jeffrey S. Miller, Melissa A. Geller, Martin Felices, Daniel A. Vallera, Behiye Kodal
Publikováno v:
Cancers, Vol 13, Iss 3994, p 3994 (2021)
Cancers
Volume 13
Issue 16
Cancers
Volume 13
Issue 16
Simple Summary HER2 is a marker known to be over-expressed on breast cancer, rendering it one of the most useful solid tumor targets for antibody-based therapies. Despite expression on ovarian cancer, results targeting HER2 in this setting have been
Autor:
Jeffrey S. Miller, Peter Hinderlie, Kristin L.M. Boylan, Amy P.N. Skubitz, L. Uppendahl, Martin Felices, Laura Bendzick, Caitlin Ryan, Melissa A. Geller, Behiye Kodal
Publikováno v:
Gynecologic Oncology. 153:149-157
Objective Natural killer (NK) cells are lymphocytes well suited for adoptive immunotherapy. Attempts with adoptive NK cell immunotherapy against ovarian cancer have proven unsuccessful, with the main limitations including failure to expand and dimini
Autor:
Svetlana Gaidarova, Hongbo Wang, Frank Cichocki, Jeffrey S. Miller, Bruce Walcheck, Brian Hancock, Miguel Meza, Ryan Bjordahl, Karrune Woan, Bruce R. Blazar, Bahram Valamehr, Janel Huffman, Melissa Khaw, Karl J. Malmberg, Ramzey Abujarour, Hansol Kim, Moyar Q. Ge, Bin Zhang, Thomas Dailey, John Goulding, Martin Felices, Cheng-Ying Wu, Tom Tong Lee, Yenan T. Bryceson, Greg Bonello, Laura Bendzick, Sajid Mahmood, Behiye Kodal, Zachary Davis, Paul Rogers, Katie Tuininga
Publikováno v:
Cell Stem Cell
2062-2075.e5
2062-2075.e5
Select subsets of immune effector cells have the greatest propensity to mediate antitumor responses. However, procuring these subsets is challenging, and cell-based immunotherapy is hampered by limited effector-cell persistence and lack of on-demand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6766136eac4f6f069666145ff5d870ee
https://hdl.handle.net/11250/2986523
https://hdl.handle.net/11250/2986523
Autor:
Joshua T. Walker, Martin Felices, Frank Cichocki, Ryan Bjordahl, Bahram Valamehr, Jeffrey S. Miller, Alexander J. Lenvik, Daniel A. Vallera, Zachary Davis, Nicholas A. Zorko, Todd Lenvik, Alejandro Garcia, Thomas H. Lee, Behiye Kodal, Svetlana Gaidarova
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background B7H3 is a tumor associated antigen (TAA), found on numerous malignancies including prostate, lung, and breast cancers. High levels of B7H3 expression are correlated with late stage disease and poor prognosis. Furthermore, B7H3 is minimally
Autor:
Jeffrey S. Miller, Alexander J. Lenvik, Charles J. Ryan, H.C. Wong, Martin Felices, Sami Chu, Kristin L.M. Boylan, Amy P.N. Skubitz, Melissa A. Geller, Behiye Kodal, Laura Bendzick
Publikováno v:
Gynecologic Oncology. 145:453-461
Objective Natural killer (NK) cells represent a powerful immunotherapeutic target as they lyse tumors directly, do not require differentiation, and can elicit potent inflammatory responses. The objective of these studies was to use an IL-15 super-ago
Autor:
Charles J. Ryan, Kristin L.M. Boylan, Melissa A. Geller, Amy P.N. Skubitz, Martin Felices, Laura Bendzick, L. Uppendahl, Behiye Kodal
Publikováno v:
Gynecologic Oncology. 149:51